<DOC>
	<DOCNO>NCT01831934</DOCNO>
	<brief_summary>This pilot clinical study , fund National Institutes Health , evaluate safety metabolic response license inactivated seasonal influenza vaccine ( TIV ) . This single arm study consist two cohort : MELAS syndrome volunteer ( specific identify disorder mitochondrial dysfunction : mitochondrial encephalopathy , lactic acidosis , stroke-like episode ) 13-60 year OR adult control volunteer 18-65 year age . Both cohort receive treatment : single vaccination FDA-licensed intramuscular seasonal trivalent inactivate influenza vaccine ( TIV ) .</brief_summary>
	<brief_title>Responses Influenza Vaccine Patients With Mitochondrial Disorders ( MELAS )</brief_title>
	<detailed_description>Mitochondrial disease constitute common neurometabolic disease childhood estimate minimal lifetime risk develop disorder 1 5000 live birth . This pilot study first time prospectively assess safety seasonal flu immunization subgroup patient MELAS syndrome . Comparing response healthy young control volunteer provide new information safety immunogenicity flu vaccination important sub-population help guide design future study carry young child . All participant receive single administration license influenza vaccine . Prior vaccination , participant provide information regard health history responses health questionnaire . Vital sign assess . A blood sample urine specimen collect prior vaccination , 6 hour , 5-7 day 26-30 day post-immunization . Volunteers ask keep diary symptom post-vaccination .</detailed_description>
	<mesh_term>Mitochondrial Diseases</mesh_term>
	<mesh_term>MELAS Syndrome</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion criterion include : Age 1360 year MELAS volunteer OR age 1865 year adult control volunteer . Control volunteer agematched +/5 year enrol MELAS volunteer . If MELAS volunteer diabetes us insulin daily , control adult diabetes us insulin daily . General good health time enrollment Willing able sign Informed Consent Available followup plan duration study Acceptable medical history screen evaluation brief clinical assessment All female participant childbearing potential must use acceptable method contraception become pregnant duration clinical phase study ( approximately 1 month completion Visit 4 ) . ( Acceptable contraception may include limited implant , injectables , combine oral contraceptive , effective intrauterine device ( IUDs ) , sexual abstinence , vasectomized partner ) . Exclusion criterion include : Allergy egg egg product allergy vaccine component , include thimerosal Active systemic serious concurrent illness , include febrile illness , within 3 day prior study vaccination History immunodeficiency , know suspected impairment immunologic function , include , limited , clinically significant liver disease , moderate severe renal disease , chronic disorder , opinion investigator , might jeopardize volunteer safety compliance protocol . Blood pressure &gt; 150 systolic &gt; 95 diastolic Visit 1 . Hospitalization past year congestive heart failure emphysema . History chronic Hepatitis B C. Recent current use immunosuppressive medication , include glucocorticoid ( corticosteroid nasal spray permissible ) . Malignancy , squamous cell basal cell skin cancer ( include solid tumor breast cancer prostate cancer recurrence past year , hematologic cancer leukemia ) . Autoimmune disease ( include rheumatoid arthritis treat immunosuppressive medication Plaquenil , methotrexate , prednisone , Enbrel ) , opinion investigator , might jeopardize volunteer safety compliance protocol . History blood dyscrasia , renal disease , hemoglobinopathies require regular medical follow hospitalization precede year Receipt blood blood product within past 6 month Medical psychiatric condition occupational responsibility preclude subject compliance protocol Inactivated vaccine 14 day prior vaccination live , attenuate vaccine within 60 day vaccination History GuillainBarr√© Syndrome Pregnant lactate woman Use investigational agent within 30 day prior enrollment Donation equivalent unit blood within 6 week prior enrollment Any condition , opinion investigator , might interfere volunteer safety , study objective ability participant understand comply study protocol .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Mitochondrial Disorder ; Immune Response ; Influenza Vaccine</keyword>
</DOC>